AstraZeneca, Merck ovarian cancer treatment improves progression-free survival

AstraZeneca, Merck ovarian cancer treatment improves progression-free survival
Reuters: Health
AstraZeneca Plc and Merck & Co Inc said on Monday their treatment for newly diagnosed advanced ovarian


Comments

Popular posts from this blog

Nadda reviews healthcare delivery mechanisms in Rajasthan, Maharashtra

Women in India Report Higher Sleep Deprivation Than Men

Ayush no longer at margins but at centre of global health discourse: Prataprao Jadhav